2-BETA-ACETOXY-4-ALPHA-CHLORO-1-BETA,8-DIANGELOYLOXY-3-BETA,10-DIHYDROXY-BISABOL-7(14),11(12)-DIENE
Compound with spectra: 1 NMR
| SpectraBase Compound ID | AeY2buZGAVb |
|---|---|
| InChI | InChI=1S/C27H39ClO8/c1-10-15(5)25(31)35-21(13-20(30)14(3)4)17(7)19-12-22(28)27(9,33)24(34-18(8)29)23(19)36-26(32)16(6)11-2/h10-11,19-24,30,33H,3,7,12-13H2,1-2,4-6,8-9H3/b15-10+,16-11+/t19-,20?,21+,22+,23+,24+,27-/m1/s1 |
| InChIKey | NSRLJPIFCTWUBI-CIMOLVEOSA-N |
| Mol Weight | 527.1 g/mol |
| Molecular Formula | C27H39ClO8 |
| Exact Mass | 526.233346 g/mol |
| Enantiomer InChIKey | NSRLJPIFCTWUBI-FCZLMEMTSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
2.beta.-Acetoxy-4.alpha.-chloro-1.beta.,8-bis[(angeloyl)oxy]-3.beta.,10,11-trihydroxybisabol-7(14)-ene
2-BETA-ACETOXY-4-ALPHA-CHLORO-1-BETA,8-DIANGELOYLOXY-3-BETA,10,11-TRIHYDROXY-BISABOL-7(14)-ENE
2.beta.-Acetoxy-4.alpha.-chloro-1.beta.,8-bis[(angeloyl)oxy]-3.beta.,10-dihydroxy-11-methoxybisabol-7(14)-ene
2-BETA-ACETOXY-1-BETA,8-DIANGELOYLOXY-4-ALPHA,10-DICHLORO-3-BETA,11-DIHYDROXY-BISABOL-7(14)-ENE
2.beta.-Acetoxy-4.alpha.,10-dichloro-1.beta.,8-bis[(angeloyl)oxy]-3.beta.,11-dihydroxybisabol-7(14)-ene
1.beta.-Acetoxy-2.beta.,8-diangeloyloxy-3.beta.,10,11-trihydroxy-4.alpha.-chlorobisabol-7(14)-ene
1.beta.-Acetoxy-2.beta.,8-diangeloyloxy-3.beta.,10-dihydroxy-4.alpha.-chloro-11-methoxybisabol-7(14)-ene
1.beta.-Acetoxy-2.beta.,8-diangeloyloxy-3.beta.-hydroxy-4.alpha.-chloro-10,11-epoxybisabol-7(14)-ene
No Name
| Title | Journal or Book | Year |
|---|---|---|
| Novel Highly Oxygenated Bisabolane Sesquiterpenes from Cremanthodium discoideum | Journal of Natural Products | 1999 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.